Raymond James & Associates’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $666K | Buy |
44,147
+4,812
| +12% | +$72.6K | ﹤0.01% | 2921 |
|
|
2024
Q2 | $557K | Buy |
39,335
+9,580
| +32% | +$136K | ﹤0.01% | 2988 |
|
|
2024
Q1 | $406K | Buy |
29,755
+3,433
| +13% | +$46.8K | ﹤0.01% | 3172 |
|
|
2023
Q4 | $354K | Sell |
26,322
-1,449
| -5% | -$19.5K | ﹤0.01% | 3154 |
|
|
2023
Q3 | $346K | Sell |
27,771
-136,694
| -83% | -$1.7M | ﹤0.01% | 3095 |
|
|
2023
Q2 | $2.23M | Sell |
164,465
-145,739
| -47% | -$1.97M | ﹤0.01% | 1982 |
|
|
2023
Q1 | $4.32M | Buy |
310,204
+54,721
| +21% | +$762K | ﹤0.01% | 1556 |
|
|
2022
Q4 | $3.63M | Buy |
255,483
+85,818
| +51% | +$1.22M | ﹤0.01% | 1637 |
|
|
2022
Q3 | $2.32M | Buy |
169,665
+157,719
| +1,320% | +$2.15M | ﹤0.01% | 1879 |
|
|
2022
Q2 | $170K | Sell |
11,946
-12,261
| -51% | -$174K | ﹤0.01% | 3535 |
|
|
2022
Q1 | $400K | Sell |
24,207
-57,169
| -70% | -$945K | ﹤0.01% | 3188 |
|
|
2021
Q4 | $1.57M | Buy |
81,376
+17,292
| +27% | +$333K | ﹤0.01% | 2331 |
|
|
2021
Q3 | $1.33M | Sell |
64,084
-29
| -0% | -$603 | ﹤0.01% | 2386 |
|
|
2021
Q2 | $1.38M | Buy |
64,113
+2,623
| +4% | +$56.3K | ﹤0.01% | 2373 |
|
|
2021
Q1 | $1.21M | Buy |
61,490
+30,412
| +98% | +$599K | ﹤0.01% | 2368 |
|
|
2020
Q4 | $614K | Sell |
31,078
-21,190
| -41% | -$419K | ﹤0.01% | 2667 |
|
|
2020
Q3 | $919K | Sell |
52,268
-1,554
| -3% | -$27.3K | ﹤0.01% | 2212 |
|
|
2020
Q2 | $967K | Sell |
53,822
-13,000
| -19% | -$234K | ﹤0.01% | 2179 |
|
|
2020
Q1 | $1M | Sell |
66,822
-21,275
| -24% | -$319K | ﹤0.01% | 1978 |
|
|
2019
Q4 | $1.54M | Sell |
88,097
-78,806
| -47% | -$1.37M | ﹤0.01% | 1996 |
|
|
2019
Q3 | $2.52M | Sell |
166,903
-49,674
| -23% | -$750K | ﹤0.01% | 1633 |
|
|
2019
Q2 | $3.65M | Sell |
216,577
-61,525
| -22% | -$1.04M | 0.01% | 1421 |
|
|
2019
Q1 | $4.76M | Sell |
278,102
-18,205
| -6% | -$312K | 0.01% | 1219 |
|
|
2018
Q4 | $4.48M | Sell |
296,307
-15,668
| -5% | -$237K | 0.01% | 1163 |
|
|
2018
Q3 | $6.37M | Buy |
311,975
+8,581
| +3% | +$175K | 0.01% | 1075 |
|
|
2018
Q2 | $5.7M | Buy |
303,394
+29,296
| +11% | +$550K | 0.01% | 1120 |
|
|
2018
Q1 | $5.27M | Buy |
274,098
+27,080
| +11% | +$520K | 0.01% | 1131 |
|
|
2017
Q4 | $4.85M | Buy |
247,018
+140,994
| +133% | +$2.77M | 0.01% | 1143 |
|
|
2017
Q3 | $2.28M | Sell |
106,024
-3,288
| -3% | -$70.6K | ﹤0.01% | 1564 |
|
|
2017
Q2 | $2.28M | Buy |
109,312
+14,039
| +15% | +$293K | ﹤0.01% | 1485 |
|
|
2017
Q1 | $1.85M | Buy |
95,273
+18,735
| +24% | +$363K | ﹤0.01% | 1574 |
|
|
2016
Q4 | $1.3M | Buy |
76,538
+57,671
| +306% | +$980K | ﹤0.01% | 1779 |
|
|
2016
Q3 | $353K | Buy |
18,867
+3,837
| +26% | +$71.8K | ﹤0.01% | 2501 |
|
|
2016
Q2 | $258K | Buy |
+15,030
| New | +$258K | ﹤0.01% | 2495 |
|
|
2016
Q1 | – | Sell |
-10,451
| Closed | -$247K | – | 2835 |
|
|
2015
Q4 | $247K | Sell |
10,451
-11,386
| -52% | -$269K | ﹤0.01% | 2265 |
|
|
2015
Q3 | $492K | Sell |
21,837
-4,193
| -16% | -$94.5K | ﹤0.01% | 1930 |
|
|
2015
Q2 | $734K | Sell |
26,030
-2,911
| -10% | -$82.1K | ﹤0.01% | 1872 |
|
|
2015
Q1 | $798K | Buy |
+28,941
| New | +$798K | ﹤0.01% | 1791 |
|
|
2014
Q3 | – | Sell |
-38,353
| Closed | -$796K | – | 2182 |
|
|
2014
Q2 | $796K | Buy |
38,353
+17,364
| +83% | +$360K | ﹤0.01% | 1622 |
|
|
2014
Q1 | $457K | Buy |
20,989
+10,900
| +108% | +$237K | ﹤0.01% | 1819 |
|
|
2013
Q4 | $206K | Buy |
+10,089
| New | +$206K | ﹤0.01% | 1942 |
|